Wavelength converting therapeutic treatment and associated methods
A wavelength converting bandage including a substrate with an external surface and an internal surface. The wavelength converting bandage includes a plurality of quantum dots, each quantum dot individually sized to emit light within a wavelength range of 613 nm to 846 nm, defined as converted light. The wavelength converting bandage includes at least a portion of the substrate constructed to adhere to skin. The substrate may receive ambient light from the environment on the external surface and may emit converted light toward the skin.
1. A wavelength converting bandage comprising:
a first cover layer comprising an absorbent pad having a thickness wherein the absorbent pad comprises spaced apart holes that extend through an entirety of the thickness of the absorbent pad;
a second cover layer; and
a substrate encapsulated between the first cover layer and the second cover layer, comprising:
an external surface;
an internal surface; and
a plurality of quantum dots, each quantum dot individually sized to emit light within a wavelength range of 613 nm to 846 nm, defined as converted light;
wherein at least a portion of the substrate is configured to adhere to skin;
wherein the substrate is configured to receive ambient light from an environment surrounding the bandage on the external surface;
wherein the internal surface is configured to emit converted light toward the skin; and
wherein the spaced apart holes of the absorbent pad are configured to permit converted light from the substrate to propagate therethrough.
2. The wavelength converting bandage of claim 1 wherein the quantum dots are contained within a suspension medium configured to coat at least a portion of the internal surface of the substrate.
3. The wavelength converting bandage of claim 1 wherein the substrate is configured to increase in temperature when exposed to ambient light.
4. The wavelength converting bandage of claim 1 wherein a radii of each of the quantum dots are configured to have a maximum axis dimension within a range of 2.8 nm to 3.2 nm.
5. The wavelength converting bandage of claim 1 wherein the substrate comprises translucent material configured to permit at least one of ambient light and converted light to propagate therethrough in a direction toward the skin.
6. A wavelength converting bandage comprising:
a first cover layer comprising an absorbent pad having a thickness wherein the absorbent pad comprises spaced apart holes that extend through an entirety of the thickness of the absorbent pad; and
a substrate, defined as a second cover layer, the substrate comprising:
an external surface;
an internal surface; and
a plurality of quantum dots sized to emit light, defined as converted light, ranging from red to infrared;
wherein at least a portion of the first cover layer is configured to adhere to skin;
wherein the second cover layer is configured to receive ambient light from an environment surrounding the bandage on the external surface and the internal surface is configured to emit converted light toward the skin; and
wherein the spaced apart holes of the absorbent pad are configured to permit converted light from the substrate to propagate therethrough.
7. The wavelength converting bandage of claim 6 wherein the converted light is emitted within a range of 613 nm to 846 nm.
8. The wavelength converting bandage of claim 6 wherein a radii of each of the quantum dots are configured to have a maximum axis dimension within a range of 2.8 nm to 3.2 nm.
9. The wavelength converting bandage of claim 6 further comprising a third cover layer; and wherein the second cover layer is encased between the first cover layer and the third cover layer.
10. The wavelength converting bandage of claim 6 wherein the second cover layer is encapsulated within a raised medial portion of the wavelength converting bandage.
11. The wavelength converting bandage of claim 6 wherein the spaced apart holes are symmetrically sized and spaced squares.
12. The wavelength converting bandage of claim 6 wherein at least a portion of the first cover layer comprises translucent material configured to permit the converted light to propagate therethrough in a direction toward the skin.
13. A wavelength converting bandage comprising:
a first cover layer comprising an absorbent pad having a thickness wherein the absorbent pad comprises spaced apart holes that extend through an entirety of the thickness of the absorbent pad;
a substrate, defined as a second cover layer, comprising:
an external surface;
an internal surface; and
a plurality of quantum dots with radii sized within a range of 2.8 nm to 3.2 nm and configured to emit light, defined as converted light, within a wavelength range of 613 nm to 846 nm; and
a third cover layer;
wherein the second cover layer is encapsulated between the first cover layer and the third cover layer;
wherein at least a portion of the first cover layer is configured to adhere to skin;
wherein the second cover layer is configured to receive ambient light from an environment surrounding the bandage on the external surface and the internal surface is configured to emit converted light toward the skin; and
wherein the spaced apart holes of the absorbent pad are configured to permit converted light from the substrate to propagate therethrough.
14. The wavelength converting bandage of claim 13 wherein the second cover layer is encapsulated within a raised medial portion of the wavelength converting bandage.
15. The wavelength converting bandage of claim 13 wherein the quantum dots are sized to emit converted light ranging from red to infrared; and wherein the second cover layer is configured to increase in temperature when exposed to ambient light.